Early test: can a drug duo help the immune system fight breast cancer?
Disease control
Completed
This small, early-stage study tested a combination of chemotherapy (nab-paclitaxel) and an immunotherapy drug (pembrolizumab) as a treatment before surgery for a common type of breast cancer. The main goal was to see how this combination changed a specific marker (PD-L1) on the p…
Phase: PHASE1 • Sponsor: Adrienne G. Waks • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC